We were proud to showcase our flagship platform, VIOSync®, at the UK Business & Trade Pavilion, alongside some of the UK’s most promising healthtech companies.
Aisthesis Medical had the privilege of exhibiting at HLTH Europe 2025, one of the continent’s premier gatherings of health innovation leaders. Hosted in Amsterdam, this year’s event brought together global startups, clinicians, investors, and policymakers focused on the future of care.
We were proud to showcase our flagship platform, VIOSync®, at the UK Business & Trade Pavilion, alongside some of the UK’s most promising healthtech companies. The conversations at our booth reflected growing momentum around AI in acute care, with clinicians and partners eager to explore solutions that are not only predictive but truly actionable.
Throughout the week, we connected with a wide network of clinical, academic, and industry stakeholders interested in validating, piloting, and scaling VIOSync® across new care settings and systems.
Thought Leadership on the HLTH Stage
In addition to our presence at the pavilion, our CEO Dr. Ioannis Gkouzionis was invited to present in two high-profile sessions:
- "Unlocking the UK’s Next-Gen Patient Care" – exploring how the NHS is embracing AI to transform frontline services
- "Stronger Together: Scaling Healthcare Innovation with AI" – a Microsoft-hosted panel featuring NVIDIA, Agora Labs, Idoven, and Aisthesis Medical
These sessions offered a chance to spotlight real-world implementation of clinical AI — emphasizing the importance of collaboration, regulation-readiness, and clinician-centered design in building trusted, scalable solutions.
Looking Ahead
Our experience at HLTH Europe validated a key insight: innovation in healthcare happens at the intersection of technology, trust, and clinical need. We return with renewed focus to accelerate hospital deployments of VIOSync®, expand research collaborations, and advance safer, earlier care for patients at risk of critical illness.
If you’re a provider, researcher, or health system interested in working together — we’d love to hear from you.
About Aisthesis Medical
Aisthesis Medical is a UK-based clinical AI company transforming how hospitals predict and respond to critical illness. Founded in 2022, we develop regulation-ready, explainable AI platforms to enable earlier, safer, and more personalised interventions in acute care.
Our flagship platform, VIOSync®, is an end-to-end sepsis care solution that predicts deterioration up to 48 hours in advance, guides treatment through protocol-based decision support, and integrates directly into EHR workflows. Unlike retrospective or opaque black-box models, VIOSync® is designed for the frontline — combining digital patient twins, explainable risk scores, and clinical pathway automation.